首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1609690

2025-2033 年日本分子诊断市场报告（依产品、技术（聚合酶炼式反应、杂交、DNA 定序、微阵列、等温核酸扩增技术等）、应用、最终用户和地区）

Japan Molecular Diagnostics Market Report by Product, Technology (Polymerase Chain Reactions, Hybridization, DNA Sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology, and Others), Application, End User, and Region 2025-2033

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 116 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2024年日本分子诊断市场IMARC Group达12亿美元。包括癌症和心血管疾病在内的慢性疾病的盛行率不断上升，老年人口需要独特的医疗保健需求和更高的特定疾病倾向，以及下一代定序和即时 PCR 等先进技术的整合代表了一些推动市场的关键因素。

分子诊断是指用于分析基因组和蛋白质组中的生物标记的技术的集合。此类诊断使医疗专业人员能够检测和测量与特定健康状况或疾病状态相关的遗传物质或蛋白质的存在。分子诊断的特点是精确度、准确性和速度，以及它们在医疗保健系统中的重要作用。这些诊断方法采用 PCR（聚合酶炼式反应）、ISH（原位杂交）和 DNA 定序等技术来揭示特定的遗传讯息。他们的工作机制涉及提取、扩增和分析遗传物质，首先是分离 DNA 或 RNA，以扩增目标遗传区域。然后透过各种方法检查扩增的遗传物质以识别突变或变化，使医疗保健提供者能够就诊断和治疗做出明智的决定。分子诊断的敏感性、特异性和同时处理多个样本的能力等特性使其在提供及时和客製化的医疗治疗方面具有优势，从而为个人化医疗提供了一个有前景的系统。

日本分子诊断市场趋势：

日本市场的主要驱动力是慢性病盛行率的不断上升，包括癌症和心血管疾病，这需要早期和精确的检测。与此一致的是，日本不断增长的老年人口，需要独特的医疗保健需求和更高的特定疾病倾向，也为市场提供了动力。此外，次世代定序和即时PCR等先进技术的整合正在成为市场的重要成长诱导因素。除此之外，日本政府在资金和有利的监管准则方面的一贯支持也为研发创造了更有利的环境。除此之外，人们对个人化医疗的认识不断增强，加上对学术机构和私人企业之间研究合作的高度重视，正在市场上创造利润丰厚的机会。此外，分子诊断平台在各种医疗保健环境中的广泛可用性正在对市场产生积极影响。对医疗基础设施的强劲投资以及公共卫生目标与技术创新的策略结合进一步推动了市场。除此之外，专注于预防保健和早期诊断的健康保险的渗透，以及专业实验室和诊所的激增，正在推动市场的发展。对该市场做出贡献的其他一些因素包括日本受过高等教育的劳动力、先进的医疗保健系统以及强调医疗科学技术精确性和创新的文化。

日本分子诊断市场细分：

产品见解：

试剂和试剂盒
仪器仪表
软体和服务

技术见解：

聚合酶炼式反应 (PCR)
杂交
DNA定序
微阵列
等温核酸扩增技术（INAAT）
其他的

应用见解：

传染病诊断
肿瘤学
基因检测
血液筛检
其他的

最终使用者见解：

医院
实验室
其他的

本报告回答的关键问题：

到目前为止，日本分子诊断市场的表现如何，未来几年又会如何表现？
COVID-19 对日本分子诊断市场有何影响？
日本分子诊断市场依产品划分是怎样的？
日本分子诊断市场在技术上的分化是什么？
日本分子诊断市场在应用上的细分如何？
日本分子诊断市场的最终用户细分如何？
日本分子诊断市场价值链的各个阶段是什么？
日本分子诊断市场的关键驱动因素和挑战是什么？
日本分子诊断市场的结构如何？
日本分子诊断市场的竞争程度如何？

本报告回答的关键问题：

日本分子诊断市场迄今表现如何，未来几年又将如何表现？
COVID-19 对日本分子诊断市场有何影响？
日本分子诊断市场依产品划分是怎样的？
日本分子诊断市场在技术上的分化是什么？
日本分子诊断市场在应用上的细分如何？
日本分子诊断市场的最终用户细分如何？
日本分子诊断市场价值链的各个阶段是什么？
日本分子诊断市场的关键驱动因素和挑战是什么？
日本分子诊断市场的结构如何？
日本分子诊断市场的竞争程度如何？

聚合酶炼式反应 (PCR)
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
杂交
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
DNA定序
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
微阵列
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
等温核酸扩增技术（INAAT）
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
其他的
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）

第 8 章：日本分子诊断市场 - 细分：按应用分类

传染病诊断
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
肿瘤学
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
基因检测
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
血液筛检
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
其他的
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）

第 9 章：日本分子诊断市场 - 细分：按最终用户划分

医院
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
实验室
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
其他的
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）

第 10 章：日本分子诊断市场 - 竞争格局

概述
市场结构
市场参与者定位
最佳制胜策略
竞争仪表板
公司评估象限

第 11 章：关键参与者简介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 12 章：日本分子诊断市场 - 产业分析

驱动因素、限制因素和机会
- 概述
- 司机
- 限制
- 机会
波特五力分析
- 概述
- 买家的议价能力
- 供应商的议价能力
- 竞争程度
- 新进入者的威胁
- 替代品的威胁
价值链分析

第 13 章：附录

简介目录

Product Code: SR112024A11068

The Japan molecular diagnostics market size reached USD 1.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.1 Billion by 2033, exhibiting a growth rate (CAGR) of 6% during 2025-2033. The increasing prevalence of chronic diseases, including cancer and cardiovascular ailments, the growing geriatric population requiring unique healthcare needs and a higher propensity for specific diseases, and the integration of advanced technologies such as next-generation sequencing and real-time PCR represent some of the key factors driving the market.

Molecular diagnostics refers to a collection of techniques used to analyze biological markers in the genome and proteome. This category of diagnostics enables medical professionals to detect and measure the presence of genetic material or proteins associated with a specific health condition or disease state. Molecular diagnostics are characterized by their precision, accuracy, and speed, as well as their essential role in the healthcare system. These diagnostic methods employ technologies such as PCR (polymerase chain reaction), ISH (in situ hybridization), and DNA sequencing to uncover specific genetic information. Their working mechanism involves extracting, amplifying, and analyzing genetic material, starting with the isolation of DNA or RNA to amplify targeted genetic regions. The amplified genetic material is then examined through various methods to identify mutations or changes, enabling healthcare providers to make informed decisions about diagnosis and treatment. The properties of molecular diagnostics such as sensitivity, specificity, and the ability to process multiple samples simultaneously make them advantageous in providing timely and tailored medical treatments, thereby offering a promising system to personalized medicine.

Japan Molecular Diagnostics Market Trends:

The market in Japan is primarily driven by the increasing prevalence of chronic diseases, including cancer and cardiovascular ailments, which necessitates the need for early and precise detection. In line with this, the growing geriatric population in Japan, requiring unique healthcare needs and a higher propensity for specific diseases, is also providing an impetus to the market. Moreover, the integration of advanced technologies such as next-generation sequencing and real-time PCR is acting as a significant growth-inducing factor for the market. In addition to this, the consistent support from the Japanese government in terms of funding and favorable regulatory guidelines is resulting in a more conducive environment for research and development. Besides this, the growing awareness about personalized medicine, coupled with a strong emphasis on research collaboration between academic institutions and private enterprises, is creating lucrative opportunities in the market. Also, the wide availability of molecular diagnostic platforms across various healthcare settings is impacting the market positively. The market is further driven by the robust investment in healthcare infrastructure and the strategic alignment of public health goals with technological innovation. Apart from this, the penetration of health insurance, focusing on preventive care and early diagnosis, along with the proliferation of specialized laboratories and clinics, is propelling the market. Some of the other factors contributing to the market include Japan's highly educated workforce, sophisticated healthcare system, and a cultural emphasis on precision and innovation in medical science and technology.

Japan Molecular Diagnostics Market Segmentation:

Product Insights:

Reagents and Kits
Instruments
Software and Services

Technology Insights:

Polymerase Chain Reactions (PCR)
Hybridization
DNA Sequencing
Microarray
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others

Application Insights:

Infectious Diseases Diagnostics
Oncology
Genetic Testing
Blood Screening
Others

End User Insights:

Hospitals
Laboratories
Others

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan molecular diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan molecular diagnostics market?
What is the breakup of the Japan molecular diagnostics market on the basis of product?
What is the breakup of the Japan molecular diagnostics market on the basis of technology?
What is the breakup of the Japan molecular diagnostics market on the basis of application?
What is the breakup of the Japan molecular diagnostics market on the basis of end user?
What are the various stages in the value chain of the Japan molecular diagnostics market?
What are the key driving factors and challenges in the Japan molecular diagnostics market?
What is the structure of the Japan molecular diagnostics market and who are the key players?
What is the degree of competition in the Japan molecular diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Molecular Diagnostics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Molecular Diagnostics Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Molecular Diagnostics Market - Breakup by Product

6.1 Reagents and Kits
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Instruments
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Software and Services
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)

7 Japan Molecular Diagnostics Market - Breakup by Technology

7.1 Polymerase Chain Reactions (PCR)
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Hybridization
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 DNA Sequencing
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Microarray
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2019-2024)
- 7.5.3 Market Forecast (2025-2033)
7.6 Others
- 7.6.1 Historical and Current Market Trends (2019-2024)
- 7.6.2 Market Forecast (2025-2033)

8 Japan Molecular Diagnostics Market - Breakup by Application

8.1 Infectious Diseases Diagnostics
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Oncology
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Genetic Testing
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Blood Screening
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Others
- 8.5.1 Historical and Current Market Trends (2019-2024)
- 8.5.2 Market Forecast (2025-2033)

9 Japan Molecular Diagnostics Market - Breakup by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Laboratories
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Others
- 9.3.1 Historical and Current Market Trends (2019-2024)
- 9.3.2 Market Forecast (2025-2033)

10 Japan Molecular Diagnostics Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Molecular Diagnostics Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis